Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Jennifer M Rendell"'
Autor:
Catherine J. Harmer, Ilina Singh, Ly-Mee Yu, Judit Simon, Paul Harrison, Glyn Lewis, Chloe Edwards, Sophie Roberts, Phil J. Cowen, Jennifer M Rendell, Sheena K. Au-Yeung, James Griffiths, Fiona Chan, Stuart Watson, Rafal Bogacz, Michael Browning, Anthony J. Cleare, Jonathan Evans, Milensu Shanyinde, John R. Geddes, David Kessler, Andrea Cipriani, M J Attenburrow
Publikováno v:
Au-Yeung, S K, Griffiths, J, Roberts, S, Edwards, C, Yu, L-M, Bogacz, R, Rendell, J, Attenburrow, M-J, Watson, S, Chan, F, Cipriani, A, Cleare, A, Harmer, C J, Kessler, D, Evans, J, Lewis, G, Singh, I, Simon, J, Harrison, P J, Cowen, P, Shanyinde, M, Geddes, J & Browning, M 2021, ' PAX-D : study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression ', Evidence-Based Mental Health . https://doi.org/10.1136/ebmental-2021-300282
IntroductionClinical depression is usually treated in primary care with psychological therapies and antidepressant medication. However, when patients do not respond to at least two or more antidepressants within a depressive episode, they are conside
Autor:
J. C. Gibson, Hasanen Al-Taiar, Alexis Economou, Jennifer M Rendell, D J Quested, F Ahmad, J Lawson, Ann L. Sharpley, John R. Geddes, J. H. Cordey, Merryn Voysey, A. Lennox, F De Crescenzo
Publikováno v:
Bipolar disordersREFERENCES. 23(2)
Objectives: Current options for treating emergent episodes of hypomania and mania in bipolar disorder are limited. Our objective was to compare the effectiveness and safety of add‐on melatonin in hypomania or mania over three weeks as a well‐tole
Publikováno v:
Bipolar Disorders
Objectives Although not licensed for acute bipolar depression, lamotrigine has evidence for efficacy in trials and its use is recommended in guidelines. So far there had been no prospective health economic evaluation of its use. Methods Cost‐utilit
Autor:
Paul Harrison, Elizabeth M. Tunbridge, M J Attenburrow, John R. Geddes, Chris Hinds, A Gardiner, Guy M. Goodwin, Merryn Voysey, Jennifer M Rendell
Publikováno v:
Bipolar Disorders. 17:50-62
Objectives Polyuria increases the risk of dehydration and lithium toxicity in lithium-treated patients. Risk factors have been inconsistently described and the variance of this adverse effect remains poorly understood. This study aimed to establish i
Autor:
Jennifer M Rendell, H McMahon, Chris Hinds, David J. Miklowitz, Guy M. Goodwin, Merryn Voysey, Amy C. Bilderbeck, Judit Simon, Lauren Z Atkinson, John R. Geddes, Emily A. Holmes, Jonathan Price
Background: Psychoeducation is an effective adjunct to medications in bipolar disorder (BD). Brief psychoeducational approaches have been shown to improve early identification of relapse. However, the optimal method of delivery of psychoeducation rem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2225b4218d306f07bf09f875bebcd60a
https://doi.org/10.1016/j.jad.2016.06.064
https://doi.org/10.1016/j.jad.2016.06.064
Autor:
Emma Van der Gucht, Richard Morriss, Ed Juszczak, Heather Young, Jane Hainsworth, Allan H. Young, Nicol Ferrier, Christine Healey, Jennifer M Rendell, John R. Geddes, Guy M. Goodwin
Objectives: The initial design of the BALANCE (Bipolar Affective disorder: Lithium / ANtiConvulsant Comparative Evaluation) Trial of maintenance treatment for bipolar disorder was based on the experience of previous trials in bipolar disorder and psy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbd4bf640644156d5ba9a4aada793a92
https://ora.ox.ac.uk/objects/uuid:b7c6ab80-2d85-4a7c-be67-1f99096a0b14
https://ora.ox.ac.uk/objects/uuid:b7c6ab80-2d85-4a7c-be67-1f99096a0b14
Objective: The integration of new treatments into the market and routine clinical practice should be dependent on robustness of evidence from randomised controlled trials (RCTs). We assessed study designs of long-term studies for bipolar disorder of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::678f7c2bf20a027839608b74d87afb4f
https://doi.org/10.1111/acps.12223
https://doi.org/10.1111/acps.12223
Autor:
Jean Christensen, David J. Miklowitz, Judit Simon, Guy M. Goodwin, Jonathan Price, Jennifer M Rendell, Joshua Wallace, Emily A. Holmes, John R. Geddes, Katie Budge, Neil Armstrong, Lily McPeake, Sarah Bell
Publikováno v:
Bipolar Disorders. 14:185-197
Miklowitz DJ, Price J, Holmes EA, Rendell J, Bell S, Budge K, Christensen J, Wallace J, Simon J, Armstrong NM, McPeake L, Goodwin GM, Geddes JR. Facilitated Integrated Mood Management for adults with bipolar disorder. Bipolar Disord 2012: 14: 185–1
Autor:
John R. Geddes, Jennifer M Rendell, William M. Stevens, David J. Miklowitz, Guy M. Goodwin, Jedediah M Bopp
Publikováno v:
Bipolar Disorders. 12:327-334
Our limited understanding of the course of mood symptoms in bipolar disorder impedes the development of effective treatments. A greater understanding of weekly fluctuations in the course of mood symptoms in bipolar disorder could improve relapse prev
Publikováno v:
Journal of Psychopharmacology. 24:1729-1738
Olanzapine was licensed in the USA by the Food and Drug Administration in 2003 for the prevention of relapse in patients with bipolar disorder when the acute manic episode had responded to treatment with olanzapine. However, olanzapine is commonly us